Using human-derived materials to repair cartilage damage
Development and Translation of Granulated Human-Derived Biomaterials for Integrative Cartilage Repair
This study is looking at a new natural material called NatruLage that comes from human sources to see if it can help heal cartilage injuries, especially for people with osteoarthritis, by encouraging the body’s own stem cells to repair the damaged cartilage.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-10912778 on NIH RePORTER |
What this research studies
This research investigates a new biomaterial called NatruLage, derived from human sources, to promote the healing of cartilage injuries. The approach focuses on how this granulated material can stimulate adult stem cells to differentiate and repair damaged cartilage, particularly in conditions like osteoarthritis. By creating a favorable environment for stem cell activity, the research aims to enhance the integration and healing of cartilage tissue. The project also emphasizes the importance of meeting regulatory standards to ensure the safety and efficacy of the new treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from cartilage injuries or osteoarthritis who are seeking innovative treatment options.
Not a fit: Patients with non-cartilage related joint issues or those who do not have cartilage damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for cartilage injuries, potentially alleviating pain and restoring function for patients with osteoarthritis.
How similar studies have performed: Previous research has shown promise in using human-derived biomaterials for tissue repair, indicating potential success for this novel approach.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Neu, Corey P — University of Colorado
- Study coordinator: Neu, Corey P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.